Edition:
United Kingdom

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

5.63USD
8:59pm GMT
Change (% chg)

$-0.19 (-3.26%)
Prev Close
$5.82
Open
$5.89
Day's High
$5.89
Day's Low
$5.39
Volume
14,212
Avg. Vol
20,686
52-wk High
$13.87
52-wk Low
$5.39

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.361
Jun '18 0.00 -0.401
Mar '18 0.00 -0.633
FY 2017 Dec '17 0.00 -0.577
Sep '17 0.00 -0.620
Jun '17 0.00 -0.733
Mar '17 0.00 -0.788
FY 2016 Dec '16 0.00 -0.546
Sep '16 0.00 -0.510
Jun '16 0.00 -0.433
Mar '16 0.00 -5.395
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 3 -0.41 -0.39 -0.42 -0.90
Quarter Ending Mar-19 2 -0.47 -0.44 -0.49 -0.86
Year Ending Dec-18 3 -1.79 -1.74 -1.83 -3.29
Year Ending Dec-19 3 -1.70 -1.52 -1.92 -3.40
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.37 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta -- 0.91 0.90
Price to Sales (TTM) -- 116.41 5.77
Price to Book (MRQ) 3.33 15.60 5.12
Price to Tangible Book (MRQ) 3.33 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 85.46 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 90.38 5.80
Sales - 5 Yr. Growth Rate -- 31.32 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -69.33 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago 57.91 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate -- 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 11.73 5.42 3.11
LT Debt to Equity (MRQ) 0.00 33.58 11.47
Total Debt to Equity (MRQ) 0.00 35.41 15.63
Interest Coverage (TTM) -- -152.90 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.20
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -506.72 11.83
Operating Margin (TTM) -- -728.64 4.90
Operating Margin - 5 Yr. Avg. -- -526.20 7.44
Pre-Tax Margin (TTM) -- -694.91 5.91
Pre-Tax Margin - 5 Yr. Avg. -- -531.06 7.89
Net Profit Margin (TTM) -- -696.69 2.16
Net Profit Margin - 5 Yr. Avg. -- -534.51 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,687,735 898,898,415
Net Income/Employee (TTM) -1,190,909 2,194,099 106,547,429
Receivable Turnover (TTM) -- 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -38.47 -1.11 11.50
Return on Assets - 5 Yr. Avg. -- 2.88 12.67
Return on Investment (TTM) -40.42 0.29 15.02
Return on Investment - 5 Yr. Avg. -- 1.84 16.45
Return on Equity (TTM) -40.82 0.94 16.60
Return on Equity - 5 Yr. Avg. -- 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -53.60 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Corvus Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 87.58%
# of Holders: 95
Total Shares Held: 25,646,144
3 Mo. Net Change: -353,471
# New Positions: 9
# Closed Positions: 5
# Increased Positions: 43
# Reduced Positions: 22
# Net Buyers: 21
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.